Skip to main content
Clinical Trials/ACTRN12622000829718
ACTRN12622000829718
Recruiting
未知

In people with nociplastic dominant chronic pain is multi-disciplinary pain management plus motivational interviewing more effective than multi-disciplinary pain management alone for improving pain self-efficacy and pain interference: a randomised controlled trial

a Trobe University0 sites184 target enrollmentJune 14, 2022

Overview

Phase
未知
Intervention
Not specified
Conditions
Chronic musculoskeletal pain
Sponsor
a Trobe University
Enrollment
184
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 14, 2022
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
a Trobe University

Eligibility Criteria

Inclusion Criteria

  • On completion of baseline assessment, physiotherapists will discuss participation in the trial if participants meet the following inclusion criteria:
  • i.have a primary complaint of chronic musculoskeletal pain (of greater than 3 months duration)
  • ii.are presumed to have a pain type of nociplastic dominant pain;
  • iii.were referred for a multidisciplinary pain management program;
  • iv.are aged between 18 and 75 years;
  • v.have sufficient fluency in English to complete all baseline and follow up questionnaires;
  • vi.have a Pain Disability Questionnaire score measure of disability of at least 50/150; and a Numerical Pain Rating Scale score of at least 3/10, to ensure that Pain Management was indicated and that there was sufficient scope for improvement to be demonstrated.

Exclusion Criteria

  • Participants will not be approached for consent if any of the following exclusion criteria are met, but reasons for exclusion will be recorded:
  • i.red flag pathologies unsuitable for pain management (active cancer, signs of cauda equina syndrome based on bladder or bowel disturbance, risk of spinal fracture, signs of potential infection, systemic inflammatory disease
  • ii.chronic cancer, pelvic or neuropathic (eg post herpatic neuralgia) pain;
  • iii.recent or pending surgery for the pain condition;
  • iv.pregnancy or childbirth within the last 6 months;
  • v.injections for the pain problem within the last 6 weeks, as we wish to study treatment effects independent to the effects of such procedures;
  • vi.have already received multi\-disciplinary pain management for the main pain problem within the last 2 years, to avoid contamination.

Outcomes

Primary Outcomes

Not specified

Similar Trials